Ferric Sulfate
drug drugOn this page
Also known as Amersep-5320Ferric persulfateFerric sulfate anhydrousFerric sulfate hydrateFerric sulphate hydrateFerric trisulfate pentahydrateIron sesquisulfateIron sulfate (fe2(so4)3)Iron sulfate (fe2(so4)3) hydratePix 115Viscostat
Summary
Ferric Sulfate (CHEMBL5095046) is a phase-3 clinical-stage small molecule; indicated across 1 condition including pulpitis.
At a glance
- Status: Max clinical phase 3 (not approved)
- Modality: Small molecule
- Indications: 1 condition
- Clinical trials: 7
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL5095046 |
| Name | Ferric Sulfate |
| Type | Small molecule |
| Max phase | 3 |
Also known as: Amersep-5320, Ferric persulfate, Ferric sulfate, Ferric sulfate anhydrous, Ferric sulfate hydrate, Ferric sulphate hydrate, Ferric trisulfate pentahydrate, Iron sesquisulfate, Iron sulfate (fe2(so4)3), Iron sulfate (fe2(so4)3) hydrate, Pix 115, Viscostat
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
Clinical trials
Total trials: 7.
Phase distribution
| Phase | Trials |
|---|---|
| Not specified | 4 |
| PHASE4 | 1 |
| PHASE2 | 1 |
| EARLY_PHASE1 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT05358509 | PHASE4 | COMPLETED | Reducing Anemia in Pregnancy in India: the RAPIDIRON Trial |
| NCT07541976 | PHASE2 | ACTIVE_NOT_RECRUITING | Comparative Evaluation of Three Different Pulpotomy Agents in Primary Molars |
| NCT05557812 | EARLY_PHASE1 | COMPLETED | A Clinical Trial Comparing FS With ZOE and Non-eugenol Based Materials in Primary Teeth Pulpotomies |
| NCT02783911 | Not specified | TERMINATED | Comparison of Mineral Trioxide Aggregate (MTA) & Ferric Sulfate (FS) Pulpotomies |
| NCT05504863 | Not specified | UNKNOWN | RAPIDIRON Trial Follow-up Study: RAPIDIRON-KIDS Study |
| NCT05545527 | Not specified | COMPLETED | Neuroimaging Ancillary Study |
| NCT07120321 | Not specified | COMPLETED | Pulpotomy Materials in Primary Molars |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.